Kalvista Pharmaceuticals Inc (KALV) PT Raised to $20 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Joseph Schwartz raised the price target on Kalvista Pharmaceuticals Inc (NASDAQ: KALV) to $20.00 (from $18.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
